Please login to the form below

Not currently logged in
Email:
Password:

Banned Chinese medicine in the UK

More than 900 packs of a potentially dangerous traditional Chinese medicine are on the UK market despite warnings issued by the MHRA

More than 900 packs of a potentially dangerous traditional Chinese medicine (TCM) are currently on the UK market despite warnings issued by the Medicines and Healthcare products Regulatory Agency (MHRA).

The unlicensed herbal product - Jingzhi Kesou Tan Chuan Wan - was distributed to 20 TCM and herbal medicine outlets throughout the UK. A recall was initiated by the distributor, Ekong International, in February 2010, however, more than three quarters of the stock brought in from China has still not been returned.

It has been revealed that new labelling in English had been applied to packs to conceal the original label, which contained the Chinese symbols for Aristolochia, a banned toxic and carcinogenic plant derivative.

Exposure to aristolochic acids can result in kidney failure and the development of cancer, particularly of the urinary tract.

The MHRA has written to TCM trade and practitioner associations to ensure that none of their members are supplying the product.

29th March 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics